EUVIMEDEUVIMED entdecken
Crossref

The effect of hyperuricemia on markers of endothelial dysfunction in patients with gout

Konstantin V Bubley, Vladimir A Beloglazov, Igor A Yatskov, Elizaveta S Ageeva

Clinical review for general practice · 27.02.2026 · 7 (1) · 46-49

DOI: 10.47407/kr2026.7.1.00752 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Clinical review for general practice, online erschienen am 27.02.2026. Verfasst von Konstantin V Bubley und 3 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Uric acid is the end product of purine metabolism in humans. The concentration of uric acid can depend on many factors, for example: diet, alcohol consumption, gender, age, and concomitant pathologies. The level of uric acid is maintained at a level that allows it to have a maximum degree of solubility in blood plasma. Studies have shown that uric acid is a powerful antioxidant at physiological concentrations. At high intracellular concentrations, uric acid has been shown to act as a pro-oxidant molecule. During the study, we focused on the pro-oxidant properties of uric acid at its non-physiological concentrations in gout patients. According to previous studies, an increased concentration of uric acid can affect the tone of the vascular wall, thereby damaging the vascular wall and causing endothelial dysfunction during prolonged exposure. The study involved 40 patients with gout. The levels of endothelin-1 (ET1), nitric oxide synthase (NOS-3), VEGF-A and C-reactive protein were measured. A correlation analysis was performed, and the strongest and most statistically significant correlation (ρ=0.515; p=0.001) was found between uric acid and ET1. The level of endothelin 1 increases markedly with increasing uric acid. In order to identify the relationship between ET1 (the dependent variable) and uric acid, a multiple linear regression was constructed. In the final model, uric acid turned out to be a significant independent predictor of ET1 levels (β=0.162; p=0.002): an increase of 1 mmol/L is associated with an increase in ET1 of about 0.162 mmol/L. Keywords: gout, hyperuricemia, endothelial dysfunction, metabolic syndrome, systemic inflammation, endothelin-1.

Zitieren

APA

Bubley, K. V., Beloglazov, V. A., Yatskov, I. A., & Ageeva, E. S. (2026). The effect of hyperuricemia on markers of endothelial dysfunction in patients with gout. Clinical review for general practice, 7(1), 46-49. https://doi.org/10.47407/kr2026.7.1.00752

Vancouver

Bubley KV, Beloglazov VA, Yatskov IA, Ageeva ES. The effect of hyperuricemia on markers of endothelial dysfunction in patients with gout. Clinical review for general practice. 2026;7(1):46-49. doi:10.47407/kr2026.7.1.00752

BibTeX
@article{Bubley2026,
  author = {Bubley, Konstantin V and Beloglazov, Vladimir A and Yatskov, Igor A and Ageeva, Elizaveta S},
  title = {The effect of hyperuricemia on markers of endothelial dysfunction in patients with gout},
  journal = {Clinical review for general practice},
  year = {2026},
  volume = {7},
  number = {1},
  pages = {46--49},
  doi = {10.47407/kr2026.7.1.00752}
}
Kostenlos starten →